Page 1029 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

33. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis 53. Kalil AC, Florescu DF. Prevalence and mortality associated
Campaign: international guidelines for themanagementof with cytomegalovirus infection in nonimmunosuppressed
severe sepsis and septic shock. Crit Care Med. 2008;36:296-327. patients in the intensive care unit. Crit Care Med. 2009;37:
34. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology 2350-2358.
of sepsis in the United States from 1979 through 2000. N Engl 54. Luyt CE, Combes A, Deback C, et al. Herpes simplex virus lung
J Med. 2003;348:1546-1554. infection in patients undergoing prolonged mechanical ventilation.
35. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA. Am J Respir Crit Care Med. 2007;175(9):935-942
Tilting toward immunosuppression. Nat Med. 2009;15:496-497. 55. Carson WF, Cavassani KA, Dou Y, Kunkel SL. Epigenetic regu-
36. Opal SM. New perspectives on immunomodulatory therapy for lation of immune cell functions during post-septic immunosup-
bacteraemia and sepsis. Int J Antimicrob Agents. 2010;36(suppl 2): pression. Epigenetics. 2011;6(3):273-283.
S70-S73. 56. Quartin AA, Schein RM, Kett DH, Peduzzi PN. Magnitude
37. Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate and duration of the effect of sepsis on survival. Department of
death and inflammation in sepsis. Nat Rev Immunol. 2006; Veterans Affairs Systemic Sepsis Cooperative Studies Group.
6:813-822. JAMA. 1997;277(13):1058-1063.
38. Osuchowski MR,Welch K, Siddiqui J, Remick DG. Circulating 57. Perl TM, Dvorak L, Hwang T, Wenzel RP. Long-term survival
cytokine/inhibitor profiles reshape the understanding of the and function after suspected gram-negative sepsis. JAMA.
SIRS/CARS continuum in sepsis and predict mortality. J Immunol. 1995;274(4):338-345.
2006;177:1967-1974. 58. Kaplan V, Clermont G, Griffin MF, et al. Pneumonia: still the
39. Adib-Conquy M, Cavaillon JM. Compensatory anti-inflammatory old man’s friend? Arch Intern Med. 2003;163:317-323.
response syndrome. Thromb Haemost. 2009;101(1):36-40 59. LaCroix AZ, Lipson S, Miles TP, White L. Prospective study of
40. Ni Choileain N, MacConmara M, Zang Y, Murphy TJ, Mannick JA, pneumonia hospitalizations and mortality of U.S. older people:
Lederer JA. Enhanced regulatory T cell activity is an element the role of chronic conditions, health behaviors, and nutritional
of the host response to injury. J Immunol. 2006;176(1):225-236. status. Public Health Rep. 1989;104:350-360.
41. Delano MJ, Scumpia PO, Weinstein JS, et al. MyD88-dependent 60. Brancati FL, Chow JW, Wagener MM, et al. Is pneumonia really
expansion of an immature GR-1(+)CD11b(+) population the old man’s friend? Two-year prognosis after community-
induces T cell suppression and Th2 polarization in sepsis. J Exp acquired pneumonia. Lancet. 1993;342:30-33.
Med. 2007;204(6):1463-1474. 61. Koivula I, Sten M, Makela PH. Prognosis after communityac-
42. Griffith TS, Yu X, Herndon JM, Green DR, Ferguson TA. CD95- quired pneumonia in the elderly: a population-based 12-year
induced apoptosis of lymphocytes in an immune privileged site follow-up study. Arch Intern Med. 1999;159:1550-1555.
induces immunological tolerance. Immunity. 1996;5(1):7-16. 62. Waterer GW, Kessler LA, Wunderink RG. Medium-term survival
43. Volk HD, Reinke P, Docke WD. Clinical aspects: from sys- after hospitalization with community-acquired pneumonia. Am J
temic inflammation to “immunoparalysis”. Chem Immunol. Respir Crit Care Med. 2004;169:910-914.
2000;74:162-177. 63. Yende S, Angus DC, Ali IS, et al. Influence of comorbid condi-
44. Monneret G. How to identify systemic sepsis-induced immuno- tions on long-term mortality after pneumonia in older people.
paralysis. Adv Sepsis. 2005;4(2):42-49. J Am Geriatr Soc. 2007;55:518-525.
45. Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes. 64. Benjamim CF, Hogaboam CM, Kunkel SL. The chronic conse-
Shock. 2001;16:83-96. quences of severe sepsis. J Leukoc Biol. 2004;75:408-412.
46. Haveman JW, Muller Kobold AC, Tervaert JW, et al. The central 65. Monneret G, Lepape A, Voirin N, et al. Persisting low monocyte
role of monocytes in the pathogenesis of sepsis. Neth J Med. human leukocyte antigen-DR expression predicts mortality in
1999;55:132-141. septic shock. Intensive Care Med. 2006;32:1175-1183
47. West MA, Heagy W. Endotoxin tolerance. Crit Care Med. 66. Landelle C, Lepape A, Voirin N, et al. Low monocyte human
2002;30:S64-S73. leukocyte antigen-DR is independently associated with nos-
48. Angele MK, Faist A. Immunodepression in the surgical ocomial infections after septic shock. Intensive Care Med.
patient and increased susceptibility to infection. Crit Care. 2010;36:1859-1866
2002;6:298-305. 67. Grienay M, Lukaszewicz A-C, Resche-Rigon M, et al. Monocytic
49. Kalil A. A silent killer: cytomegalovirus infection in the HLA-DR expression in intensive care patients: interest for
immunocompromised critically ill patient. Crit Care Med. prognosis and secondary infection prediction. Crit Care Med.
2008;36:3261-3264. 2009;37(10):2746-2752.
50. Ziemann M, Sedemund-Adib, ReiBland R, Schmucker P, 68. Schefold JC. Measurement of monocytic HLA-DR (mHLA-DR)
Henning H. Increased mortality in long-term intensive care expression in patients with severe sepsis and septic shock:
patients with active cytomegalovirus infection. Crit Care Med. assessment of immune organ failure. Intensive Care Med.
2008;36:3145-3150. 2010;36:1810-1812.
51. Monneret G, Venet F, Pachot A, Lepape A. Monitoring immune 69. Hobson MJ, Wong HR. Finding new therapies for sepsis: the
dysfunctions in the septic patient: a new skin for the old need for patient stratification and the use of genetic biomarkers.
ceremony. Mol Med. 2008;14:64-78. Crit Care. 2011;15:1009.
52. Monneret G, Venet F, Kullberg BJ, Netea MG. ICU-acquired 70. Gogos CA, Drosou E, Bassaris HP, et al. Pro- versus anti-
immunosuppression and the risk for secondary fungal inflammatory cytokine profile in patients with severe sepsis.
infections. Med Mycol. 2011;49(suppl 1):S17-S23. J Infect Dis. 2000;181:176-180.

Section05-O-ref.indd 2 1/20/2015 4:51:16 PM